Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.25    0.15 (0.33%)
Bid:
45.25
Ask:
46.00
Spread: 0.75 (1.657%)
Market Cap: £286.37m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Statement regarding press speculation

29 Jan 2021 11:24

RNS Number : 3843N
Marston's PLC
29 January 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY FIRM OFFER WILL BE MADE NOR AS TO THE TERMS ON WHICH ANY FIRM OFFER MIGHT BE MADE.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

Friday 29th January, 2021Marston's PLC

Statement regarding press speculation

The Board of Marston's PLC ("Marston's" or the "Company") notes the press speculation and confirms that it has today received an unsolicited non-binding proposal from Platinum Equity Advisors, LLC ("Platinum") regarding a possible cash offer for the entire issued, and to be issued, share capital of Marston's (the "Proposal").

The Board will evaluate the Proposal with its advisers and a further announcement will be made in due course. There can be no certainty that any firm offer will be made for the Company, nor as to the terms on which any firm offer might be made.

In accordance with Rule 2.6(a) of the Code, Platinum, is required, by no later than 5.00 p.m. (London time) on Friday 26th February 2021, being 28 days after today's date, to either announce a firm intention to make an offer for the Company in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Takeover Panel (the "Panel") in accordance with Rule 2.6(c) of the Code.

Enquiries:

 

Marston's PLC

Tel: 01902 329516

Ralph Findlay, CEO

Andrew Andrea, CFO

J.P. Morgan Cazenove

Tel: 020 7742 4000

James Mitford / Anastasia Volnova

Dwayne Lysaght / Jonty Edwards

Instinctif Partners

Tel: 020 7457 2010/2005

Justine Warren

Matthew Smallwood

 

 

Disclaimer

J.P. Morgan Securities PLC, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated in the United Kingdom by the PRA and the Financial Conduct Authority. J.P. Morgan Cazenove is acting as financial adviser exclusively for Marston's and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Marston's for providing the protections afforded to clients of J.P. Morgan Cazenove, or for providing advice in relation to any matter referred to herein.

Rule 26.1 Disclosure

In accordance with Rule 26.1 of the Code, a copy of this announcement will be available at www.marstons.co.uk, by no later than 12 noon (London time) on 1st February 2021. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any securities exchange offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any securities exchange offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) of the Code applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any securities exchange offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a securities exchange offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any securities exchange offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any securities exchange offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any securities exchange offeror, save to the extent that these details have previously been disclosed under Rule 8 of the Code. A Dealing Disclosure by a person to whom Rule 8.3(b) of the Code applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a securities exchange offeror, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4 of the Code).

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. You should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129 if you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCUKUARAUUAUAR
Date   Source Headline
28th Jan 20113:23 pmRNSResult of AGM
28th Jan 20117:00 amRNSAGM and Interim Management Statement
11th Jan 20115:31 pmRNSBlocklisting Interim Review
4th Jan 20117:00 amRNSTotal Voting Rights
20th Dec 20105:12 pmRNSAnnual Financial Report
20th Dec 201010:34 amRNSAnnual Information Update
2nd Dec 20107:00 amRNSPreliminary Results
30th Nov 20101:37 pmRNSTotal Voting Rights
29th Nov 20104:03 pmRNSHolding(s) in Company
26th Nov 20103:33 pmRNSNeil Goulden Appointed Chairman of Audit Committee
29th Oct 201011:51 amRNSTotal Voting Rights
6th Oct 20107:00 amRNSTrading Statement
30th Sep 20109:56 amRNSTotal Voting Rights
28th Sep 201011:17 amRNSBlocklisting Interim Review
1st Sep 201012:56 pmRNSNotice of Forthcoming Events
31st Aug 20104:15 pmRNSTotal Voting Rights
23rd Aug 201011:37 amRNSDirector/PDMR Shareholding
19th Aug 20107:00 amRNSAppointment of Non Executive Director
4th Aug 20107:00 amRNSInterim Management Statement
30th Jul 201011:13 amRNSTotal Voting Rights
5th Jul 20102:49 pmRNSHolding(s) in Company
2nd Jul 201010:50 amRNSDirector/PDMR Shareholding
1st Jul 20109:03 amRNSTotal Voting Rights
28th Jun 20103:39 pmRNSDirector/PDMR Shareholding
24th Jun 20107:00 amRNSAnalyst Visit
21st Jun 20109:40 amRNSNotice of Interim Management Statement
1st Jun 20109:18 amRNSTotal Voting Rights
25th May 20102:44 pmRNSDirector/PDMR Shareholding
21st May 20108:55 amRNSDirector/PDMR Shareholding
20th May 20107:00 amRNSInterim Results
30th Apr 201011:36 amRNSTotal Voting Rights
7th Apr 20107:00 amRNSTrading Statement
31st Mar 20104:23 pmRNSTotal Voting Rights
25th Mar 20107:15 amRNSAppointment Of Joint Broker
26th Feb 20102:39 pmRNSTotal Voting Rights
19th Feb 20107:00 amRNSNotice of Trading Update
8th Feb 20102:00 pmRNSDirector/PDMR Shareholding
3rd Feb 201012:56 pmRNSDirector/PDMR Shareholding
1st Feb 20107:00 amRNSNotice of Results
29th Jan 20104:39 pmRNSResult of AGM
29th Jan 20107:00 amRNSAGM and Interim Management Statement
28th Jan 201010:14 amRNSTotal Voting Rights
11th Jan 201010:50 amRNSDisclosure of charges over shares by PDMR
5th Jan 20109:49 amRNSTotal Voting Rights
21st Dec 20094:05 pmRNSAnnual Financial Report
18th Dec 20093:10 pmRNSAnnual Information Update
10th Dec 200910:00 amRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSFinal Results
19th Nov 20091:10 pmRNSDirector/PDMR Shareholding
29th Oct 20093:44 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.